Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01811628 · ClinicalTrials.gov registry record
Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 26
- Enrollment target
NCT01811628: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01811628 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01811628 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The goal of this research study is to collect information from Latino and Hispanic smokers and recent quitters about factors that are important to them when they are trying to quit. Researchers want to better understand some of the challenges and problems that Latinos and Hispanics face when they try to quit smoking, and then use that information to design a treatment for future smokers.
Primary Outcome
Primary aim of this study is to conduct in-person qualitative interviews with 48 Latino smokers or recent quitters in order to gather information regarding potential elements to include in a future intervention that will target smoking cessation treatment adherence among Latino smokers. This exploratory and qualitative study will utilize thematic analyses of interview discussions to analyze and derive elements that will ultimately be included in a treatment manual. Data analyzed using thematic
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-07-17 |
| Est. Completion | 2017-07-14 |
What the finished NCT01811628 record still lists
NCT01811628 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT01811628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01811628 about?
NCT01811628 is a clinical study titled "Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers". The goal of this research study is to collect information from Latino and Hispanic smokers and recent quitters about factors that are important to them when they are trying to quit. Researchers want to better understand some of the challenges and problems that Latinos and Hispanics face when they tr...
What is the current status of trial NCT01811628?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2013-07-17. Estimated completion is 2017-07-14.
What interventions are being tested in trial NCT01811628?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT01811628?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI